Related Experiment Video

Updated: Jun 11, 2025

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

8.4K

Lessons from a negative gene therapy trial for Duchenne muscular dystrophy

Simone Spuler1, Gian Domenico Borasio2, Ulrike Grittner3

  • 1Muscle Research Unit, Charité Universitätsmedizin Berlin and Max Delbrück Center, Berlin, Germany. simone.spuler@charite.de.

Nature Medicine
|October 9, 2024
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

6.8K
Exon Skipping in Directly Reprogrammed Myotubes Obtained from Human Urine-Derived Cells
06:20

Exon Skipping in Directly Reprogrammed Myotubes Obtained from Human Urine-Derived Cells

Published on: May 7, 2020

7.0K

Related Experiment Videos

Last Updated: Jun 11, 2025

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

8.4K
Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

6.8K
Exon Skipping in Directly Reprogrammed Myotubes Obtained from Human Urine-Derived Cells
06:20

Exon Skipping in Directly Reprogrammed Myotubes Obtained from Human Urine-Derived Cells

Published on: May 7, 2020

7.0K

Related Concept Videos

Gene Therapy00:59

Gene Therapy

25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

1.9K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K

Articles linked to this work by shared authors, journal, and citation graph.

"I Make Myself Very Small in My Corner": Purposeful Withdrawal as an Expression of Patient Altruism.

Journal of pain and symptom management·2026

Understanding posttraumatic growth in palliative care: a qualitatively driven mixed-methods study using patients' life narratives.

BMC palliative care·2026

Identification of prognostic biomarkers in a large cohort of patients with LGMD R2.

Journal of neurology·2026

Multicentric prognostic observational study on biomarker profile in immunotherapy-naïve patients with highly active generalized myasthenia gravis (PROGNO-MG): a study protocol.

Neurological research and practice·2026

Harmonizing the stimulation dose of focal transcranial direct current stimulation across target sites.

NeuroImage·2026

Baseline Cerebral Small Vessel Disease Predicting Long-Term Cognitive Decline in Transient Ischemic Attack Patients.

European journal of neurology·2026

Immunotherapy with a short-lived anti-PD-L1 antibody in Alzheimer's disease: a phase 1b, randomized, double-blind trial.

Nature medicine·2026

Oligonucleotide-siRNA conjugate for SOD1 amyotrophic lateral sclerosis: a phase 1 trial.

Nature medicine·2026

An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial.

Nature medicine·2026

Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.

Nature medicine·2026

Health system learning enables generalist neuroimaging models.

Nature medicine·2026

KRAS-G12D inhibitor HRS-4642 plus chemotherapy in advanced KRASG12D-mutant pancreatic cancer: a phase 1b/2 trial.

Nature medicine·2026

Safety evaluation of an extension of use of the food enzyme α-amylase from the non-genetically modified Bacillus amyloliquefaciens strain LMG-S 32676.

EFSA journal. European Food Safety Authority·2026

Safety evaluation of an extension of use of the food enzyme α-amylase from the non-genetically modified Aspergillus oryzae strain NZYM-NA.

EFSA journal. European Food Safety Authority·2026

The Use of Coffee Residues as Sustainable Cultivation Substrates in Microbial Biotechnology: Up-to-Date Review and Future Perspectives.

Molecules (Basel, Switzerland)·2026

Safety evaluation of the food enzyme pectin lyase from the non-genetically modified Aspergillus luchuensis strain CBS 141530.

EFSA journal. European Food Safety Authority·2026

Evidence-based recommendations for shower-out practices: assessing virus removal from hair using a surrogate non-enveloped virus.

Microbiology spectrum·2026

Safety evaluation of an extension of use of the food enzyme endo-1,3(4)-β-glucanase from the non-genetically modified Rasamsonia composticola strain 427-FS.

EFSA journal. European Food Safety Authority·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us